Angola vs Belize: Cause of death, by non-communicable diseases, ages 60+
Angola
66.3%
in 2021
Belize
66.0%
in 2021
Angola rank
118th
Belize rank
119th
Cause of death, by non-communicable diseases, ages 60+ over time
- Angola
- Belize
How they compare
Angola currently reports 66.3% against 66.0% in Belize, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Belize ahead.
Angola ranks 118th and Belize ranks 119th of 185 countries.
Belize has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Belize | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.1% | 85.9% | 19.7% | Belize |
| 2010s | 69.0% | 84.9% | 15.9% | Belize |
| 2020s | 68.7% | 72.6% | 3.8% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Angola or Belize?
- Angola, at 66.3% against 66.0% in Belize as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Angola and Belize?
- 0.3%, with Angola ahead.
- How many years of comparable data are there for Angola and Belize?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Belize rank globally for cause of death, by non-communicable diseases, ages 60+?
- Angola ranks 118th and Belize ranks 119th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.